Biologics utilization for psoriasis is lower in black compared with white patients

Br J Dermatol. 2021 Jul;185(1):207-209. doi: 10.1111/bjd.19876. Epub 2021 Apr 18.

Authors

W T Hodges¹, T Bhat¹, N S Raval¹, C Herbosa¹, P Ugwu-Dike², S G Kwatra³, A Musiek¹, C Mann¹, Y R Semenov²

Affiliations

¹ Division of Dermatology, Washington University School of Medicine, St. Louis, MO, USA.
² Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.
³ Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

PMID: 33567102
DOI: 10.1111/bjd.19876

No abstract available

Publication types

Letter

MeSH terms

Biological Factors
Biological Products* / therapeutic use
Black or African American
Humans
Psoriasis* / drug therapy

Substances

Biological Factors
Biological Products